Diethylamine

Diethylamine

SCHEMBL4566735

CC(C)(C)c1ccc(S(=O)(=O)n2cc(C(=O)N3CCCCC3)c3cc(Cl)ccc32)cc1.CCNCC

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CCKAR

The experimentally established mechanism targets of Diethylamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ACLY P53396 2/20 0.54
HTR6 P50406 4/20 0.44
CNR2 P34972 1/20 0.43
CNR1 P21554 1/20 0.42
ALDH1A1 P00352 1/20 0.41
HPGD P15428 1/20 0.41
TP53 P04637 2/20 0.41
ALOX5 P09917 1/20 0.40
EPHX2 P34913 1/20 0.40
POLB P06746 1/20 0.40
FLT1 P17948 1/20 0.40
FLT4 P35916 1/20 0.40
KDR P35968 1/20 0.40
LMNA P02545 1/20 0.39
GAA P10253 1/20 0.39
GLA P06280 1/20 0.39
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3132217 0.94 ACLY (0.60) ACLYHTR6CNR2CNR1ALDH1A1
SCHEMBL3146270 0.85 ACLY (0.55) ACLYHTR6CNR2HPGDTP53
SCHEMBL3133970 0.84 ACLY (0.54) ACLYHTR6ALDH1A1POLBLMNA
SCHEMBL3132165 0.79 AKR1C3 (0.50) ACLYHTR6FLT1FLT4KDR
SCHEMBL3133901 0.78 PLK1 (0.55) ACLYHTR6EPHX2FLT1FLT4
SCHEMBL3137579 0.78 FLT1 (0.46) ACLYHTR6EPHX2FLT1FLT4
SCHEMBL3141520 0.78 FLT1 (0.47) ACLYHTR6EPHX2FLT1FLT4
SCHEMBL3145976 0.76 HDAC1 (0.48) ACLYHTR6FLT1FLT4KDR
SCHEMBL3131370 0.75 FLT1 (0.47) ACLYHTR6EPHX2FLT1FLT4
SCHEMBL22003852 0.70 ACLY (1.00) ACLY

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2118060-A1 1-BENZENESULFONYL-1H-INDOLE DERIVATIVES AS INHIBITORS OF CCR9 ACTIVITY Novartis AG (CH) 2009-11-18 EP disclosed
WO-2008095908-A1 1-BENZENESULFONYL-1H-INDOLE DERIVATIVES AS INHIBITORS OF CCR9 ACTIVITY NOVARTIS AG (CH) 2008-08-14 WO disclosed